Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity
Open Access
- 5 November 2021
- journal article
- research article
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 8 (1) , e001038
Abstract
Introduction Obstructive lung diseases (asthma and chronic obstructive pulmonary disease (COPD)) and smoking are associated with greater risk of respiratory infections and hospitalisations, but conflicting data exist regarding their association with severity of COVID-19, and few studies have evaluated whether these associations differ by age. Objectives To examine the associations between asthma, COPD and smoking on the severity of COVID-19 among a cohort of hospitalised patients, and to test for effect modification by age. Methods We performed a retrospective analysis of electronic health record data of patients admitted to Massachusetts General Hospital, assigning the maximal WHO Clinical Progression Scale score for each patient during the first 28 days following hospital admission. Using ordered logistic regression, we measured the association between maximal severity score and asthma, COPD and smoking and their interaction with age. Measurements and main results Among 1391 patients hospitalised with COVID-19, we found an increased risk of severe disease among patients with COPD and prior smoking, independent of age. We also found evidence of effect modification by age with asthma and current smoking; in particular, asthma was associated with decreased COVID-19 severity among older adults, and current smoking was associated with decreased severity among younger patients. Conclusions This cohort study identifies age as a modifying factor for the association between asthma and smoking on severity of COVID-19. Our findings highlight the complexities of determining risk factors for COVID-19 severity, and suggest that the effect of risk factors may vary across the age spectrum.Keywords
Funding Information
- Cystic Fibrosis Foundation (YONKER18Q0)
- National Institutes of Health (5K08HL143183, K23ES030399-03, R01AG062393, R01HL132786, R37AI058736-16S1, UL1TR002541)
This publication has 63 references indexed in Scilit:
- Asthma phenotypes: the evolution from clinical to molecular approachesNature Medicine, 2012
- Nicotine Exerts an Anti-inflammatory Effect in a Murine Model of Acute Lung InjuryInflammation, 2010
- Cigarette Smoke Exposure Impairs Pulmonary Bacterial Clearance and Alveolar Macrophage Complement-Mediated Phagocytosis of Streptococcus pneumoniaeInfection and Immunity, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Comparison of the Sp o 2 /F io 2 Ratio and the Pa o 2 /F io 2 Ratio in Patients With Acute Lung Injury or ARDSChest, 2007
- Regular Smoking and Asthma Incidence in AdolescentsAmerican Journal of Respiratory and Critical Care Medicine, 2006
- The vagus nerve and the nicotinic anti-inflammatory pathwayNature Reviews Drug Discovery, 2005
- Cigarette Smoking and Invasive Pneumococcal DiseaseNew England Journal of Medicine, 2000
- Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohortBMJ, 1996
- The Pulmonary-Alveolar MacrophageNew England Journal of Medicine, 1979